Expression and Processing of the Neuroendocrine Protein Secretogranin II in Benign and Malignant Pheochromocytomas
- 1 August 2006
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1073 (1) , 527-532
- https://doi.org/10.1196/annals.1353.056
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Biochemical Characterisation and Immunohistochemical Localisation of the Secretogranin II‐Derived Peptide EM66 in the Hypothalamus of the Jerboa (Jaculus orientalis): Modulation by Food DeprivationJournal of Neuroendocrinology, 2005
- Opposite regulation of the mitochondrial apoptotic pathway by C2‐ceramide and PACAP through a MAP‐kinase‐dependent mechanism in cerebellar granule cellsJournal of Neurochemistry, 2004
- Identification of the Secretogranin II-Derived Peptide EM66 in Pheochromocytomas as a Potential Marker for Discriminating BenignVersusMalignant TumorsJournal of Clinical Endocrinology & Metabolism, 2003
- The Chromogranin–Secretogranin FamilyNew England Journal of Medicine, 2003
- PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cellsEuropean Journal of Neuroscience, 2003
- Secretoneurin: a functional neuropeptide in health and diseasePeptides, 2000
- Proteolytic Processing of Chromogranin B and Secretogranin II by Prohormone ConvertasesJournal of Neurochemistry, 1998
- Secretogranin II (SgII) distribution and processing studies in human normal and adenomatous anterior pituitaries using new polyclonal antibodiesRegulatory Peptides, 1997
- Cloning and Primary Sequence of a Mouse Candidate Prohormone Convertase PC1 Homologous to PC2, Furin, and Kex2: Distinct Chromosomal Localization and Messenger RNA Distribution in Brain and Pituitary Compared to PC2Molecular Endocrinology, 1991